Spectrum Pharmaceuticals Defeats Claims by CTI Over Joint Venture

CTI v. Spectrum Pharmaceuticals

Defended Spectrum Pharmaceuticals from claims asserted against it by CTI arising out of a joint venture agreement. Spectrum asserted cross-claims against CTI arising out of the same joint venture. After a full hearing, the arbitrator denied CTI all relief on its complaint, and granted Spectrum all relief requested.*